$ARIA Recent Headlines J.C. Penney and more of the year's

New Post Public Reply Private Reply Replies (0) Message Board

Dec 18, 2013 at 10:54 AM

$ARIA Recent Headlines

J.C. Penney and more of the year's most profitable shorts 3:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 8:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com
Stocks: Investors play the waiting game 8:53 a.m. Dec. 11, 2012 - The Trading Deck
12 biotech stocks hit 52-week highs 2:43 p.m. July 27, 2012 - Val Brickates Kennedy
Three rules for short selling 12:01 a.m. Feb. 2, 2012 - The Trading Deck
Stocks to watch Wednesday: C.R. Bard, Papa John’s 6:52 a.m. Dec. 21, 2011 - MarketWatch
Don't be a fan when investing 8:26 a.m. Dec. 20, 2011 - The Trading Deck
Drug stocks move higher in late trading 2:26 p.m. March 24, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:12 p.m. Jan. 18, 2011 - Kate Gibson
Ariad soars as drug indexes move higher 12:47 p.m. Jan. 18, 2011 - Val Brickates Kennedy
Ariad rallies as drug indexes modestly rise 10:23 a.m. Jan. 18, 2011 - Val Brickates Kennedy

Ariad Pharmaceuticals - Positive News From Regulators 8:46 a.m. Today - Seeking Alpha
The Worst Biotech CEO of 2013 Is... 7:58 a.m. Dec. 17, 2013 - TheStreet.com
Your Vote Counts: Who is the Worst Biotech CEO of 2013? 8:32 a.m. Dec. 12, 2013 - TheStreet.com
9 Biotechnology Stocks to Buy Now 6:00 a.m. Dec. 11, 2013 - InvestorPlace.com
UPDATE: Stifel Upgrades Ariad Pharmaceuticals on Physician Enthusiasm at ASH 10:23 a.m. Dec. 10, 2013 - benzinga.com
Iclusig to return "in time": Summer Street 10:02 a.m. Dec. 10, 2013 - Seeking Alpha
Bad News Biotechs Of 2013 7:00 a.m. Dec. 10, 2013 - Seeking Alpha
ARIAD Loses as EMA Deliberates on Iclusig - Analyst Blog 4:30 p.m. Dec. 9, 2013 - Zacks.com
Jefferies lifts target on Ariad as Iclusig debate continues 9:32 a.m. Dec. 9, 2013 - Seeking Alpha
Ariad Pharmaceuticals (ARIA) Flagged As Today's Pre-Market Laggard 8:15 a.m. Dec. 9, 2013 - TheStreet.com
Ariad Pharmaceuticals (ARIA): Today's Featured Health Care Laggard 5:01 p.m. Dec. 6, 2013 - TheStreet.com
7 Biotechnology Stocks to Buy Now 6:30 a.m. Dec. 4, 2013 - InvestorPlace.com
3 Best Performing Stocks of November in Focus - Analyst Blog 5:34 p.m. Dec. 2, 2013 - Zacks.com
Today's Pre-Market Trading Very Positive For Ariad Pharmaceuticals (ARIA) 7:52 a.m. Dec. 2, 2013 - TheStreet.com
Biotech Stocks Partying Like It's 1999 7:00 a.m. Dec. 2, 2013 - TheStreet.com
Benzinga's Top #PreMarket Losers 7:19 a.m. Nov. 29, 2013 - benzinga.com
Four Biotech 'Surprise' Stocks for 2014 7:00 a.m. Nov. 27, 2013 - TheStreet.com
5 Biotechnology Stocks to Buy Now 7:00 a.m. Nov. 27, 2013 - InvestorPlace.com
Wednesday’s Biggest Stock Losers: BLOX, BRLI and More 5:10 a.m. Nov. 27, 2013 - InvestorPlace.com
Nuance and ARIAD Are Volume Movers for Very Different Reasons 11:24 a.m. Nov. 26, 2013 - 247WallSt.com

Published Data, Stock Price Movements, and FDA Approvals - Research Report on Johnson & Johnson, Ariad Pharmaceuticals, PerkinElmer, BD, and Sanofi 8:00 a.m. Dec. 13, 2013 - PR Newswire
Morning Buzz: Facebook Inc, BlackBerry Ltd, Ariad Pharmaceuticals, Nokia Corporation 11:19 a.m. Dec. 12, 2013 - ACCESSWIRE
Stocks Of The Day: Alpha Natural Resources, Apple Inc, Ariad Pharmaceuticals, Verizon Communications 10:40 a.m. Dec. 9, 2013 - ACCESSWIRE
Faruqi & Faruqi, LLP Files Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. (ARIA) 8:00 p.m. Dec. 6, 2013 - PR Newswire
UPCOMING DEADLINE: Levi & Korsinsky, LLP Announces Class Action Against ARIAD Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ARIA 6:11 p.m. Dec. 5, 2013 - PR Newswire
Blue Chip Stock News: Ariad Pharmaceuticals, Citigroup Inc, Arena Pharmaceuticals, Market Vectors Gold Miners 9:45 a.m. Dec. 5, 2013 - ACCESSWIRE
Stock Price Movements, Campaigns, New Clinical Studies, and Approvals- Research Report on Actavis, Ariad Pharmaceuticals, DaVita, Celldex, and WellCare 8:00 a.m. Dec. 5, 2013 - PR Newswire
MolecularMD Announces Presentations at Upcoming American Society of Hematology Annual Meeting 7:00 a.m. Dec. 5, 2013 - Marketwire
Labaton Sucharow LLP Has Filed a Class Action Lawsuit on Behalf of Investors in Ariad Pharmaceuticals, Inc. -- ARIA 6:28 p.m. Dec. 3, 2013 - GlobeNewswire
ARIAD Announces Iclusig Data Presentations at Annual American Society of Hematology Meeting 7:35 a.m. Dec. 3, 2013 - BusinessWire
TrendingWallStreet.com Reports Volume Coverage on ZOOM, FARE, BAC, and ARIA 12:26 a.m. Dec. 3, 2013 - ACCESSWIRE
ARIA, AAPL, EBAY and CAMT added to NASDAQ Active Stock Watch List at EPR 10:34 a.m. Dec. 2, 2013 - ACCESSWIRE
Traders Buzz: Tesla Motors Inc, Sirius XM Radio, Microsoft Corporation, Ariad Pharmaceuticals 9:35 a.m. Dec. 2, 2013 - ACCESSWIRE
TrendingWallStreet.com Starts Volume Coverage on AAPL, IACH, ARIA, and JCP 12:45 a.m. Dec. 2, 2013 - ACCESSWIRE
Positive Opinion, Program Honorees, Positive Medical Results, and Investor Day - Research Report on Bristol-Myers Squibb, Ariad Pharmaceuticals, Dyax, Ironwood Pharmaceuticals, and Immunomedics 8:00 a.m. Nov. 27, 2013 - PR Newswire
Pre-Market Breakdown: Galena Biopharma Inc., Novavax Inc., Ariad Pharma Inc., and MannKind Corp. 8:00 a.m. Nov. 27, 2013 - PR Newswire
TrendingWallStreet.com Begins Market Coverage on NLY, VEND, ARIA, and FB 12:15 a.m. Nov. 27, 2013 - ACCESSWIRE
Must Watch Stocks: Ariad Pharmaceuticals, Hewlett-Packard Company, Camtek Ltd, Buka Ventures Inc 9:01 a.m. Nov. 26, 2013 - ACCESSWIRE
TrendingWallStreet.com Initiates Analysis on BAC, NVGC, ARIA, and C 12:16 a.m. Nov. 26, 2013 - ACCESSWIRE
ARIA, SIRI, DVAX and UNXL added to NASDAQ Active Stock Watch List at GSR 10:10 a.m. Nov. 25, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces a Legal Countdown – Investors Take Note

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Lundbeck's Board Leadership Transitions into New Era

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

AEVEX Faces 48-Hour Deadline for Investor Class Action

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Antheia Secures $80M for Critical Medicine Onshoring

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Tomorrowland's Shanghai Return: An Electri-Lifesaver

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

UEG's New Advisory Board: Elevating Patient Voices

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Faith and Resilience in China: The Legacy of the Long March

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...